ENOV — Enovis Corporation stock price and chart

ENOV

$20.69+4.13%

as of close, Oct 20, 2026

☾ AH $20.69 +4.13%

Enovis CorporationStock · HealthcareRussell 2000 · 0.04% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.001% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDSEEEEEEEEEEEE

20162019202120242026

20.030.040.050.060.070.080.090.0010.0M$20.69

2026-10-20

Price$20.69

MA20$22.80

MA50$25.32

Vol5.5M

What would $1,000 invested in ENOV be worth today? →

ENOV returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $20.69
YTD price return: -22.33%
YTD total return: -22.33%
Next earnings: Nov 5, 2026 · Before open
Market cap: 1.2B2016-12 2.5B2026-10 1.2B-52.8% over the window
Enterprise value: 2.5B
Shares outstanding: 57.7M2016-07 40.9M2026-07 57.7M+41.0% over the window
52W low: $16.70
52W high: $34.28
From 52W high: -39.64%
From 52W low: +23.89%
52W range: 23%

Volume

Rel volume: 0.67×
30D volume: 1.7M
30D $ vol: 31.7M

Fundamentals

Sales (ttm): 2.3B2016-07 3.6B2026-07 2.3B-36.9% over the window
Sales/share: $39.822016-07 $88.962026-07 $39.82-55.2% over the window
EPS (ttm): -$19.222016-07 $3.032026-07 -$19.22-734.3% over the window
FCF (ttm): 63.7M2016-07 216.3M2026-07 63.7M-70.6% over the window
FCF/share: $1.102016-07 $5.292026-07 $1.10-79.1% over the window
Book value/share: $25.612016-07 $72.522026-07 $25.61-64.7% over the window
Net margin: -47.97%2016-07 3.4%2026-07 -48.0%-1496.7% over the window
ROE: -74.59%2016-07 4.2%2026-07 -74.6%-1870.3% over the window
ROA: -29.25%2016-07 1.9%2026-07 -29.3%-1639.9% over the window
Debt / equity: 0.84×2016-07 0.472026-07 0.84+78.8% over the window
Current ratio: 1.982016-07 1.642026-07 1.98+20.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +4.91%2025-07-04 → 2026-07-032.2B → 2.3B (+4.9% total)+12.13%2023-06-30 → 2026-07-031.6B → 2.3B (+41.1% total)+11.16%2021-12-31 → 2026-07-031.4B → 2.3B (+61.0% total)-4.49%2016-07-01 → 2026-07-033.6B → 2.3B (-36.9% total)
FCF: n/an/a-26.32%2021-12-31 → 2026-07-03251.9M → 63.7M (-74.7% total)-11.51%2016-07-01 → 2026-07-03216.3M → 63.7M (-70.6% total)
Shares: +0.89%2025-07-04 → 2026-07-0357.2M → 57.7M (+0.9% total)+1.87%2023-06-30 → 2026-07-0354.5M → 57.7M (+5.7% total)+1.56%2021-12-31 → 2026-07-0353.8M → 57.7M (+7.2% total)+3.50%2016-07-01 → 2026-07-0340.9M → 57.7M (+41.0% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +3.97%2025-07-04 → 2026-07-03$38.31 → $39.82 (+4.0% total)+10.07%2023-06-30 → 2026-07-03$29.83 → $39.82 (+33.5% total)+9.45%2021-12-31 → 2026-07-03$26.52 → $39.82 (+50.2% total)-7.72%2016-07-01 → 2026-07-03$88.96 → $39.82 (-55.2% total)
FCF/share: n/an/a-27.45%2021-12-31 → 2026-07-03$4.68 → $1.10 (-76.4% total)-14.50%2016-07-01 → 2026-07-03$5.29 → $1.10 (-79.1% total)
Book value/share: -43.33%2025-07-04 → 2026-07-03$45.10 → $25.61 (-43.2% total)-25.94%2023-06-30 → 2026-07-03$63.23 → $25.61 (-59.5% total)-23.55%2021-12-31 → 2026-07-03$85.86 → $25.61 (-70.2% total)-9.88%2016-07-01 → 2026-07-03$72.52 → $25.61 (-64.7% total)
Price: -36.18%2025-10-20 → 2026-10-20$32.41 → $20.69 (-36.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-22.51%2023-10-20 → 2026-10-20$44.47 → $20.69 (-53.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-25.09%2021-10-20 → 2026-10-20$87.71 → $20.69 (-76.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-8.54%2016-10-19 → 2026-10-20$50.55 → $20.69 (-59.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -36.18%2025-10-20 → 2026-10-20$32.41 → $20.69 (-36.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-22.51%2023-10-20 → 2026-10-20$44.47 → $20.69 (-53.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-25.09%2021-10-20 → 2026-10-20$87.71 → $20.69 (-76.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-8.54%2016-10-19 → 2026-10-20$50.55 → $20.69 (-59.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -1.1×2016-12 18.792026-10 -1.08-105.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 13.2×2016-12 11.172026-10 -1.15-110.3% over the window
Fwd P/E: 5.8×
P/S (ttm)Market cap ÷ TTM revenue.: 0.5×2016-12 0.742026-10 0.52-29.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 0.8×2016-12 0.852026-10 0.81-5.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 18.7×2016-12 14.472026-10 18.74+29.5% over the window
EV/EBITDA (fy): 8.3×
EV/Sales (ttm): 1.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 5.34%2016-09 6.9%2026-07 5.3%-22.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-07-03) ÷ shares_at(2025-07-04) = 1 − 57.7M ÷ 57.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.89%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.89%) + dividends paid over that year ($0) ÷ market_cap_at(2025-07-04) ($1.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.89%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($2.2M) ÷ today's market cap ($1.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.18%2016-09 1.8%2026-07 0.2%-89.7% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $2.2M + TTM dividends $0) ÷ today's market cap ($1.2B). Same caveat as the cash buyback yield.: 0.18%2016-09 1.8%2026-07 0.2%-89.7% over the window

Vs own 10Y history

P/E: 63rd
P/OI: 58th
P/S: 10th
P/B: 52nd
P/FCF: 59th

Bar = where today’s multiple sits in ENOV’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+4.13%

+8.95%

+14.69%

-22.91%

YTD

-22.33%

-36.16%

-76.41%

Financial statements

Open full ENOV financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

ENOV — Enovis Corporation price, chart and key statistics